Signals and cells involved in regulating liver regeneration

Cells

Volumn 1, Issue 4, 2012, Pages 1261-1292

  Kang, Liang I ^a   Mars, Wendy M ^a   Michalopoulos, George K ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Epidermal growth factor; Hepatocyte; Hepatocyte growth factor; Liver regeneration; Oval cell; Partial hepatectomy; Transdifferentitation

Indexed keywords

ACTIVIN; AMPHIREGULIN; BETA CATENIN; BILE ACID; CARBON TETRACHLORIDE; CONSTITUTIVE ANDROSTANE RECEPTOR; CYTOKINE; DIAZEPAM; EPIDERMAL GROWTH FACTOR RECEPTOR; FIBROBLAST GROWTH FACTOR; GLYPICAN 3; INSULIN; INTEGRIN LINKED KINASE; INTERLEUKIN 6; MESSENGER RNA; NEUROTRANSMITTER; NORADRENALIN; PARACETAMOL; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PHENOBARBITAL; PHENYTOIN; SCATTER FACTOR; SEROTONIN; SEROTONIN TRANSPORTER; SONIC HEDGEHOG PROTEIN; TRANSCRIPTION FACTOR YAP1; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR; UNINDEXED DRUG; WNT PROTEIN;

BONE MARROW; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CELL TRANSDIFFERENTIATION; DISEASE ASSOCIATION; DNA SYNTHESIS; HEPATOMEGALY; HUMAN; INFLAMMATORY INFILTRATE; KUPFFER CELL; LIVER CELL; LIVER CELL DAMAGE; LIVER REGENERATION; LIVER SIZE; NONHUMAN; PARTIAL HEPATECTOMY; REVIEW; SIGNAL TRANSDUCTION; STEM CELL;

EID: 84881522730     PISSN: None     EISSN: 20734409     Source Type: Journal    
DOI: 10.3390/cells1041261     Document Type: Review

References (229)

1. Wolber, E.M.; Jelkmann, W. Thrombopoietin: The novel hepatic hormone. News Physiol. Sci. 2002, 17, 6-10.
2. Michalopoulos, G.K. Liver regeneration after partial hepatectomy: critical analysis of mechanistic dilemmas. Am. J. Pathol. 2010, 176, 2-13.
3. Miyaoka, Y.; Ebato, K.; Kato, H.; Arakawa, S.; Shimizu, S.; Miyajima, A. Hypertrophy and unconventional cell division of hepatocytes underlie liver regeneration. Curr. Biol. 2012, 22, 1166-1175.
4. Lim, Y.S.; Kim, W.R. The global impact of hepatic fibrosis and end-stage liver disease. Clin. Liver Dis. 2008, 12, 733-746, vii.
5. Parker, G.A.; Picut, C.A. Immune functioning in non lymphoid organs: The liver. Toxicol. Pathol. 2012, 40, 237-247.
6. Friedman, S.L. Hepatic stellate cells: Protean, multifunctional, and enigmatic cells of the liver. Physiol. Rev. 2008, 88, 125-172.
7. Higgins, G.M.; Anderson, R.M. Experimental pathology of the liver-Restoration of the liver of the white rat following partial surgical removal. Arch. Pathol. 1931, 12, 186-202.
8. Mitchell, C.; Willenbring, H. A reproducible and well-tolerated method for 2/3 partial hepatectomy in mice. Nat. Protoc. 2008, 3, 1167-1170.
9. de Toranzo, E.G.; Gomez, M.I.; Castro, J.A. Carbon tetrachloride activation, lipid peroxidation and liver necrosis in different strains of mice. Res. Commun. Chem. Pathol. Pharmacol. 1978, 19, 347-352.
10. DeCicco, L.A.; Rikans, L.E.; Tutor, C.G.; Hornbrook, K.R. Serum and liver concentrations of tumor necrosis factor alpha and interleukin-1beta following administration of carbon tetrachloride to male rats. Toxicol. Lett. 1998, 98, 115-121.
11. Jaeschke, H.; McGill, M.R.; Williams, C.D.; Ramachandran, A. Current issues with acetaminophen hepatotoxicity a clinically relevant model to test the efficacy of natural products. Life Sci. 2011, 88, 737-745.
12. Hinson, J.A.; Roberts, D.W.; James, L.P. Mechanisms of acetaminophen-induced liver necrosis. Handb. Exp. Pharmacol. 2010, 369-405.
13. David Josephy, P. The molecular toxicology of acetaminophen. Drug Metab. Rev. 2005, 37, 581-594.
14. Lee, J.H.; Ilic, Z.; Sell, S. Cell kinetics of repair after allyl alcohol-induced liver necrosis in mice. Int. J. Exp. Pathol. 1996, 77, 63-72.
15. Pound, A.W.; McGuire, L.J. Repeated partial hepatectomy as a promoting stimulus for carcinogenic response of liver to nitrosamines in rats. Br. J. Cancer. 1978, 37, 585-594.
16. Bhave, V.S.; Donthamsetty, S.; Latendresse, J.R.; Cunningham, M.L.; Mehendale, H.M. Secretory phospholipase A(2)-mediated progression of hepatotoxicity initiated by acetaminophen is exacerbated in the absence of hepatic COX-2. Toxicol. Appl. Pharmacol. 2011, 251, 173-180.
17. Bhave, V.S.; Donthamsetty, S.; Latendresse, J.R.; Muskhelishvili, L.; Mehendale, H.M. Secretory phospholipase A2 mediates progression of acute liver injury in the absence of sufficient cyclooxygenase-2. Toxicol. Appl. Pharmacol. 2008, 228, 225-238.
18. Limaye, P.B.; Bhave, V.S.; Palkar, P.S.; Apte, U.M.; Sawant, S.P.; Yu, S.; Latendresse, J.R.; Reddy, J.K.; Mehendale, H.M. Upregulation of calpastatin in regenerating and developing rat liver: role in resistance against hepatotoxicity. Hepatology 2006, 44, 379-388.
19. Mehendale, H.M. Once initiated, how does toxic tissue injury expand? Trends Pharmacol. Sci. 2012, 33, 200-206.
20. Mehendale, H.M. Tissue repair: an important determinant of final outcome of toxicant-induced injury. Toxicol. Pathol. 2005, 33, 41-51.
21. Columbano, A.; Ledda-Columbano, G.M. Mitogenesis by ligands of nuclear receptors: an attractive model for the study of the molecular mechanisms implicated in liver growth. Cell Death Differ. 2003, 10 (Suppl. 1), S19-S21.
22. Columbano, A.; Simbula, M.; Pibiri, M.; Perra, A.; Deidda, M.; Locker, J.; Pisanu, A.; Uccheddu, A.; Ledda-Columbano, G.M. Triiodothyronine stimulates hepatocyte proliferation in two models of impaired liver regeneration. Cell Prolif. 2008, 41, 521-531.
23. Malik, R.; Habib, M.; Tootle, R.; Hodgson, H. Exogenous thyroid hormone induces liver enlargement, whilst maintaining regenerative potential a study relevant to donor preconditioning. Am. J. Transplant. 2005, 5, 1801-1807.
24. Francavilla, A.; Carr, B.I.; Azzarone, A.; Polimeno, L.; Wang, Z.; Van Thiel, D.H.; Subbotin, V.; Prelich, J.G.; Starzl, T.E. Hepatocyte proliferation and gene expression induced by triiodothyronine in vivo and in vitro. Hepatology 1994, 20, 1237-1241.
25. Pyper, S.R.; Viswakarma, N.; Yu, S.; Reddy, J.K. PPARalpha: energy combustion, hypolipidemia, inflammation and cancer. Nucl. Recept. Signal. 2010, 8, e002.
26. Qatanani, M.; Moore, D.D. CAR, the continuously advancing receptor, in drug metabolism and disease. Curr. Drug Metab. 2005, 6, 329-339.
27. Ledda-Columbano, G.M.; Coni, P.; Simbula, G.; Zedda, I.; Columbano, A. Compensatory regeneration, mitogen-induced liver growth, and multistage chemical carcinogenesis. Environ. Health Perspect. 1993, 101 (Suppl. 5), 163-168.
28. Bursch, W.; Taper, H.S.; Lauer, B.; Schulte-Hermann, R. Quantitative histological and histochemical studies on the occurrence and stages of controlled cell death (apoptosis) during regression of rat liver hyperplasia. Virchows Arch. B Cell Pathol. Incl. Mol. Pathol. 1985, 50, 153-166.
29. Columbano, A.; Ledda-Columbano, G.M.; Coni, P.P.; Faa, G.; Liguori, C.; Santa Cruz, G.; Pani, P. Occurrence of cell death (apoptosis) during the involution of liver hyperplasia. Lab. Invest. 1985, 52, 670-675.
30. Columbano, A.; Shinozuka, H. Liver regeneration versus direct hyperplasia. FASEB J. 1996, 10, 1118-1128.
31. Apte, U.; Gkretsi, V.; Bowen, W.C.; Mars, W.M.; Luo, J.H.; Donthamsetty, S.; Orr, A.; Monga, S.P.; Wu, C.; Michalopoulos, G.K. Enhanced liver regeneration following changes induced by hepatocyte-specific genetic ablation of integrin-linked kinase. Hepatology 2009, 50, 844-851.
32. Liu, B.; Bell, A.W.; Paranjpe, S.; Bowen, W.C.; Khillan, J.S.; Luo, J.H.; Mars, W.M.; Michalopoulos, G.K. Suppression of liver regeneration and hepatocyte proliferation in hepatocyte-targeted glypican 3 transgenic mice. Hepatology 2010, 52, 1060-1067.
33. Donthamsetty, S.; Bowen, W.; Mars, W.; Bhave, V.; Luo, J.H.; Wu, C.; Hurd, J.; Orr, A.; Bell, A.; Michalopoulos, G. Liver-specific ablation of integrin-linked kinase in mice results in enhanced and prolonged cell proliferation and hepatomegaly after phenobarbital administration. Toxicol. Sci. 2010, 113, 358-366.
34. Donthamsetty, S.; Bhave, V.S.; Kliment, C.S.; Bowen, W.C.; Mars, W.M.; Bell, A.W.; Stewart, R.E.; Orr, A.; Wu, C.; Michalopoulos, G.K. Excessive hepatomegaly of mice with hepatocytetargeted elimination of integrin linked kinase following treatment with 1,4-bis [2-(3,5-dichaloropyridyloxy)] benzene. Hepatology 2011, 53, 587-595.
35. Lin, C.W.; Mars, W.M.; Paranjpe, S.; Donthamsetty, S.; Bhave, V.S.; Kang, L.I.; Orr, A.; Bowen, W.C.; Bell, A.W.; Michalopoulos, G.K. Hepatocyte proliferation and hepatomegaly induced by phenobarbital and 1,4-bis [2-(3,5-dichloropyridyloxy)] benzene is suppressed in hepatocyte-targeted glypican 3 transgenic mice. Hepatology 2011, 54, 620-630.
36. Kodama, S.; Negishi, M. Phenobarbital confers its diverse effects by activating the orphan nuclear receptor car. Drug. Metab. Rev. 2006, 38, 75-87.
37. Marubashi, S.; Sakon, M.; Nagano, H.; Gotoh, K.; Hashimoto, K.; Kubota, M.; Kobayashi, S.; Yamamoto, S.; Miyamoto, A.; Dono, K.; Nakamori, S.; Umeshita, K.; Monden, M. Effect of portal hemodynamics on liver regeneration studied in a novel portohepatic shunt rat model. Surgery 2004, 136, 1028-1037.
38. Francavilla, A.; Starzl, T.E.; Porter, K.; Foglieni, C.S.; Michalopoulos, G.K.; Carrieri, G.; Trejo, J.; Azzarone, A.; Barone, M.; Zeng, Q.H. Screening for candidate hepatic growth factors by selective portal infusion after canine Eck's fistula. Hepatology 1991, 14, 665-670.
39. Kim, T.H.; Mars, W.M.; Stolz, D.B.; Petersen, B.E.; Michalopoulos, G.K. Extracellular matrix remodeling at the early stages of liver regeneration in the rat. Hepatology 1997, 26, 896-904.
40. Kim, T.H.; Mars, W.M.; Stolz, D.B.; Michalopoulos, G.K. Expression and activation of pro-MMP-2 and pro-MMP-9 during rat liver regeneration. Hepatology 2000, 31, 75-82.
41. Mars, W.M.; Zarnegar, R.; Michalopoulos, G.K. Activation of hepatocyte growth factor by the plasminogen activators uPA and tPA. Am. J. Pathol. 1993, 143, 949-958.
42. Mars, W.M.; Kim, T.H.; Stolz, D.B.; Liu, M.L.; Michalopoulos, G.K. Presence of urokinase in serum-free primary rat hepatocyte cultures and its role in activating hepatocyte growth factor. Cancer Res. 1996, 56, 2837-2843.
43. Mars, W.M.; Liu, M.L.; Kitson, R.P.; Goldfarb, R.H.; Gabauer, M.K.; Michalopoulos, G.K. Immediate early detection of urokinase receptor after partial hepatectomy and its implications for initiation of liver regeneration. Hepatology 1995, 21, 1695-1701.
44. Kohler, C.; Bell, A.W.; Bowen, W.C.; Monga, S.P.; Fleig, W.; Michalopoulos, G.K. Expression of Notch-1 and its ligand Jagged-1 in rat liver during liver regeneration. Hepatology 2004, 39, 1056-1065.
45. Monga, S.P.; Pediaditakis, P.; Mule, K.; Stolz, D.B.; Michalopoulos, G.K. Changes in WNT/beta-catenin pathway during regulated growth in rat liver regeneration. Hepatology. 2001, 33, 1098-1109.
46. Monga, S.P. Role of Wnt/beta-catenin signaling in liver metabolism and cancer. Int. J. Biochem. Cell Biol. 2011, 43, 1021-1029.
47. Haber, B.A.; Mohn, K.L.; Diamond, R.H.; Taub, R. Induction patterns of 70 genes during nine days after hepatectomy define the temporal course of liver regeneration. J. Clin. Invest. 1993, 91, 1319-1326.
48. Mohn, K.L.; Laz, T.M.; Melby, A.E.; Taub, R. Immediate-early gene expression differs between regenerating liver, insulin-stimulated H-35 cells, and mitogen-stimulated Balb/c 3T3 cells. Liverspecific induction patterns of gene 33, phosphoenolpyruvate carboxykinase, and the jun, fos, and egr families. J. Biol. Chem. 1990, 265, 21914-21921.
49. Strey, C.W.; Winters, M.S.; Markiewski, M.M.; Lambris, J.D. Partial hepatectomy induced liver proteome changes in mice. Proteomics 2005, 5, 318-325.
50. Taub, R. Liver regeneration: from myth to mechanism. Nat. Rev. Mol. Cell Biol. 2004, 5, 836-847.
51. Fausto, N.; Campbell, J.S.; Riehle, K.J. Liver regeneration. Hepatology 2006, 43, S45-S53.
52. Zarnegar, R.; Michalopoulos, G. Purification and biological characterization of human hepatopoietin A, a polypeptide growth factor for hepatocytes. Cancer Res. 1989, 49, 3314-3320.
53. Nakamura, T.; Teramoto, H.; Ichihara, A. Purification and characterization of a growth factor from rat platelets for mature parenchymal hepatocytes in primary cultures. Proc. Natl. Acad. Sci. USA 1986, 83, 6489-6493.
54. Nakamura, T.; Nishizawa, T.; Hagiya, M.; Seki, T.; Shimonishi, M.; Sugimura, A.; Tashiro, K.; Shimizu, S. Molecular cloning and expression of human hepatocyte growth factor. Nature. 1989, 342, 440-443.
55. Zarnegar, R.; Muga, S.; Enghild, J.; Michalopoulos, G. NH2-terminal amino acid sequence of rabbit hepatopoietin A, a heparin-binding polypeptide growth factor for hepatocytes. Biochem Biophys. Res. Commun. 1989, 163, 1370-1376.
56. Wang, X.; DeFrances, M.C.; Dai, Y.; Pediaditakis, P.; Johnson, C.; Bell, A.; Michalopoulos, G.K.; Zarnegar, R. A mechanism of cell survival: sequestration of Fas by the HGF receptor Met. Mol. Cell. 2002, 9, 411-421.
57. Fafalios, A.; Ma, J.; Tan, X.; Stoops, J.; Luo, J.; Defrances, M.C.; Zarnegar, R. A hepatocyte growth factor receptor (Met)-insulin receptor hybrid governs hepatic glucose metabolism. Nat. Med. 2011, 17, 1577-1584.
58. Nakamura, T. Hepatocyte growth factor as mitogen, motogen and morphogen, and its roles in organ regeneration. Princess Takamatsu Symp. 1994, 24, 195-213.
59. Paranjpe, S.; Bowen, W.C.; Bell, A.W.; Nejak-Bowen, K.; Luo, J.H.; Michalopoulos, G.K. Cell cycle effects resulting from inhibition of hepatocyte growth factor and its receptor c-Met in regenerating rat livers by RNA interference. Hepatology. 2007, 45, 1471-1477.
60. Wang, B.; Gao, C.; Ponder, K.P. C/EBPbeta contributes to hepatocyte growth factor-induced replication of rodent hepatocytes. J. Hepatol. 2005, 43, 294-302.
61. Schuppan, D.; Schmid, M.; Somasundaram, R.; Ackermann, R.; Ruehl, M.; Nakamura, T.; Riecken, E.O. Collagens in the liver extracellular matrix bind hepatocyte growth factor. Gastroenterology 1998, 114, 139-152.
62. Liu, M.L.; Mars, W.M.; Zarnegar, R.; Michalopoulos, G.K. Uptake and distribution of hepatocyte growth factor in normal and regenerating adult rat liver. Am. J. Pathol. 1994, 144, 129-140.
63. Stolz, D.B.; Mars, W.M.; Petersen, B.E.; Kim, T.H.; Michalopoulos, G.K. Growth factor signal transduction immediately after two-thirds partial hepatectomy in the rat. Cancer Res. 1999, 59, 3954-3960.
64. Pediaditakis, P.; Lopez-Talavera, J.C.; Petersen, B.; Monga, S.P.; Michalopoulos, G.K. The processing and utilization of hepatocyte growth factor/scatter factor following partial hepatectomy in the rat. Hepatology 2001, 34, 688-693.
65. Lindroos, P.M.; Zarnegar, R.; Michalopoulos, G.K. Hepatocyte growth factor (hepatopoietin A) rapidly increases in plasma before DNA synthesis and liver regeneration stimulated by partial hepatectomy and carbon tetrachloride administration. Hepatology 1991, 13, 743-750.
66. Schirmacher, P.; Geerts, A.; Pietrangelo, A.; Dienes, H.P.; Rogler, C.E. Hepatocyte growth factor/hepatopoietin A is expressed in fat-storing cells from rat liver but not myofibroblast-like cells derived from fat-storing cells. Hepatology 1992, 15, 5-11.
67. LeCouter, J.; Moritz, D.R.; Li, B.; Phillips, G.L.; Liang, X.H.; Gerber, H.P.; Hillan, K.J.; Ferrara, N. Angiogenesis-independent endothelial protection of liver: role of VEGFR-1. Science 2003, 299, 890-893.
68. Maher, J.J. Cell-specific expression of hepatocyte growth factor in liver. Upregulation in sinusoidal endothelial cells after carbon tetrachloride. J. Clin. Invest. 1993, 91, 2244-2252.
69. Zarnegar, R.; DeFrances, M.C.; Kost, D.P.; Lindroos, P.; Michalopoulos, G.K. Expression of hepatocyte growth factor mRNA in regenerating rat liver after partial hepatectomy. Biochem. Biophys. Res. Commun. 1991, 177, 559-565.
70. Kono, S.; Nagaike, M.; Matsumoto, K.; Nakamura, T. Marked induction of hepatocyte growth factor mRNA in intact kidney and spleen in response to injury of distant organs. Biochem. Biophys. Res. Commun. 1992, 186, 991-998.
71. Yanagita, K.; Nagaike, M.; Ishibashi, H.; Niho, Y.; Matsumoto, K.; Nakamura, T. Lung may have an endocrine function producing hepatocyte growth factor in response to injury of distal organs. Biochem. Biophys. Res. Commun. 1992, 182, 802-809.
72. Broten, J.; Michalopoulos, G.; Petersen, B.; Cruise, J. Adrenergic stimulation of hepatocyte growth factor expression. Biochem. Biophys. Res. Commun. 1999, 262, 76-79.
73. Skrtic, S.; Wallenius, V.; Ekberg, S.; Brenzel, A.; Gressner, A.M.; Jansson, J.O. Insulin-like growth factors stimulate expression of hepatocyte growth factor but not transforming growth factor beta1 in cultured hepatic stellate cells. Endocrinology 1997, 138, 4683-4689.
74. McGowan, J.A.; Strain, A.J.; Bucher, N.L. DNA synthesis in primary cultures of adult rat hepatocytes in a defined medium: effects of epidermal growth factor, insulin, glucagon, and cyclic-AMP. J. Cell. Physiol. 1981, 108, 353-363.
75. Bucher, N.L.; Patel, U.; Cohen, S. Hormonal factors concerned with liver regeneration. Ciba Found. Symp. 1977, 95-107.
76. St Hilaire, R.J.; Hradek, G.T.; Jones, A.L. Hepatic sequestration and biliary secretion of epidermal growth factor: evidence for a high-capacity uptake system. Proc. Natl. Acad. Sci. USA 1983, 80, 3797-3801.
77. St Hilaire, R.J.; Jones, A.L. Epidermal growth factor: its biologic and metabolic effects with emphasis on the hepatocyte. Hepatology 1982, 2, 601-613.
78. Olsen, P.S.; Poulsen, S.S.; Kirkegaard, P. Adrenergic effects on secretion of epidermal growth factor from Brunner's glands. Gut 1985, 26, 920-927.
79. Jones, D.E., Jr.; Tran-Patterson, R.; Cui, D.M.; Davin, D.; Estell, K.P.; Miller, D.M. Epidermal growth factor secreted from the salivary gland is necessary for liver regeneration. Am. J. Physiol. 1995, 268, G872-G878.
80. Reddy, C.C.; Wells, A.; Lauffenburger, D.A. Receptor-mediated effects on ligand availability influence relative mitogenic potencies of epidermal growth factor and transforming growth factor alpha. J. Cell. Physiol. 1996, 166, 512-522.
81. Webber, E.M.; FitzGerald, M.J.; Brown, P.I.; Bartlett, M.H.; Fausto, N. Transforming growth factor-alpha expression during liver regeneration after partial hepatectomy and toxic injury, and potential interactions between transforming growth factor-alpha and hepatocyte growth factor. Hepatology 1993, 18, 1422-1431.
82. Luetteke, N.C.; Lee, D.C. Transforming growth factor alpha: expression, regulation and biological action of its integral membrane precursor. Semin. Cancer Biol. 1990, 1, 265-275.
83. Lee, D.C.; Sunnarborg, S.W.; Hinkle, C.L.; Myers, T.J.; Stevenson, M.Y.; Russell, W.E.; Castner, B.J.; Gerhart, M.J.; Paxton, R.J.; Black, R.A.; Chang, A.; Jackson, L.F. TACE/ADAM17 processing of EGFR ligands indicates a role as a physiological convertase. Ann. N. Y. Acad. Sci. 2003, 995, 22-38.
84. Mead, J.E.; Fausto, N. Transforming growth factor alpha may be a physiological regulator of liver regeneration by means of an autocrine mechanism. Proc. Natl. Acad. Sci. USA 1989, 86, 1558-1562.
85. Russell, W.E.; Kaufmann, W.K.; Sitaric, S.; Luetteke, N.C.; Lee, D.C. Liver regeneration and hepatocarcinogenesis in transforming growth factor-alpha-targeted mice. Mol. Carcinog. 1996, 15, 183-189.
86. Berasain, C.; Garcia-Trevijano, E.R.; Castillo, J.; Erroba, E.; Lee, D.C.; Prieto, J.; Avila, M.A. Amphiregulin: an early trigger of liver regeneration in mice. Gastroenterology 2005, 128, 424-432.
87. Michalopoulos, G.K.; Khan, Z. Liver regeneration, growth factors, and amphiregulin. Gastroenterology 2005, 128, 503-506.
88. Kiso, S.; Kawata, S.; Tamura, S.; Higashiyama, S.; Ito, N.; Tsushima, H.; Taniguchi, N.; Matsuzawa, Y. Role of heparin-binding epidermal growth factor-like growth factor as a hepatotrophic factor in rat liver regeneration after partial hepatectomy. Hepatology 1995, 22, 1584-1590.
89. Ito, N.; Kawata, S.; Tamura, S.; Kiso, S.; Tsushima, H.; Damm, D.; Abraham, J.A.; Higashiyama, S.; Taniguchi, N.; Matsuzawa, Y. Heparin-binding EGF-like growth factor is a potent mitogen for rat hepatocytes. Biochem. Biophys. Res. Commun. 1994, 198, 25-31.
90. Mitchell, C.; Nivison, M.; Jackson, L.F.; Fox, R.; Lee, D.C.; Campbell, J.S.; Fausto, N. Heparinbinding epidermal growth factor-like growth factor links hepatocyte priming with cell cycle progression during liver regeneration. J. Biol. Chem. 2005, 280, 2562-2568.
91. Kiso, S.; Kawata, S.; Tamura, S.; Inui, Y.; Yoshida, Y.; Sawai, Y.; Umeki, S.; Ito, N.; Yamada, A.; Miyagawa, J.; Higashiyama, S.; Iwawaki, T.; Saito, M.; Taniguchi, N.; Matsuzawa, Y.; Kohno, K. Liver regeneration in heparin-binding EGF-like growth factor transgenic mice after partial hepatectomy. Gastroenterology 2003, 124, 701-707.
92. Paranjpe, S.; Bowen, W.C.; Tseng, G.C.; Luo, J.H.; Orr, A.; Michalopoulos, G.K. RNA interference against hepatic epidermal growth factor receptor has suppressive effects on liver regeneration in rats. Am. J. Pathol. 2010, 176, 2669-2681.
93. Natarajan, A.; Wagner, B.; Sibilia, M. The EGF receptor is required for efficient liver regeneration. Proc. Natl. Acad. Sci. USA 2007, 104, 17081-17086.
94. Bradham, C.A.; Plumpe, J.; Manns, M.P.; Brenner, D.A.; Trautwein, C. Mechanisms of hepatic toxicity. I. TNF-induced liver injury. Am. J. Physiol. 1998, 275, G387-G392.
95. Hatano, E.; Bennett, B.L.; Manning, A.M.; Qian, T.; Lemasters, J.J.; Brenner, D.A. NF-kappaB stimulates inducible nitric oxide synthase to protect mouse hepatocytes from TNF-alpha-and Fas-mediated apoptosis. Gastroenterology 2001, 120, 1251-1262.
96. Hatano, E.; Brenner, D.A. Akt protects mouse hepatocytes from TNF-alpha-and Fas-mediated apoptosis through NK-kappa B activation. Am. J. Physiol. Gastrointest. Liver Physiol. 2001, 281, G1357-G1368.
97. Leist, M.; Gantner, F.; Bohlinger, I.; Tiegs, G.; Germann, P.G.; Wendel, A. Tumor necrosis factor-induced hepatocyte apoptosis precedes liver failure in experimental murine shock models. Am. J. Pathol. 1995, 146, 1220-1234.
98. Leist, M.; Gantner, F.; Jilg, S.; Wendel, A. Activation of the 55 kDa TNF receptor is necessary and sufficient for TNF-induced liver failure, hepatocyte apoptosis, and nitrite release. J. Immunol. 1995, 154, 1307-1316.
99. Leist, M.; Gantner, F.; Kunstle, G.; Bohlinger, I.; Tiegs, G.; Bluethmann, H.; Wendel, A. The 55-kD tumor necrosis factor receptor and CD95 independently signal murine hepatocyte apoptosis and subsequent liver failure. Mol. Med. 1996, 2, 109-124.
100. Akerman, P.; Cote, P.; Yang, S.Q.; McClain, C.; Nelson, S.; Bagby, G.J.; Diehl, A.M. Antibodies to tumor necrosis factor-alpha inhibit liver regeneration after partial hepatectomy. Am J. Physiol. 1992, 263, G579-G585.
101. Yamada, Y.; Webber, E.M.; Kirillova, I.; Peschon, J.J.; Fausto, N. Analysis of liver regeneration in mice lacking type 1 or type 2 tumor necrosis factor receptor: Requirement for type 1 but not type 2 receptor. Hepatology 1998, 28, 959-970.
102. Iimuro, Y.; Nishiura, T.; Hellerbrand, C.; Behrns, K.E.; Schoonhoven, R.; Grisham, J.W.; Brenner, D.A. NFkappaB prevents apoptosis and liver dysfunction during liver regeneration. J. Clin. Invest. 1998, 101, 802-811.
103. Webber, E.M.; Bruix, J.; Pierce, R.H.; Fausto, N. Tumor necrosis factor primes hepatocytes for DNA replication in the rat. Hepatology 1998, 28, 1226-1234.
104. Webber, E.M.; Godowski, P.J.; Fausto, N. In vivo response of hepatocytes to growth factors requires an initial priming stimulus. Hepatology 1994, 19, 489-497.
105. Gauldie, J.; Northemann, W.; Fey, G.H. IL-6 functions as an exocrine hormone in inflammation. Hepatocytes undergoing acute phase responses require exogenous IL-6. J. Immunol. 1990, 144, 3804-3808.
106. Castell, J.V.; Gomez-Lechon, M.J.; David, M.; Fabra, R.; Trullenque, R.; Heinrich, P.C. Acutephase response of human hepatocytes: regulation of acute-phase protein synthesis by interleukin-Hepatology 1990, 12, 1179-1186.
107. Streetz, K.L.; Wustefeld, T.; Klein, C.; Manns, M.P.; Trautwein, C. Mediators of inflammation and acute phase response in the liver. Cell. Mol. Biol. (Noisy-le-grand) 2001, 47, 661-673.
108. Peters, M.; Muller, A.M.; Rose-John, S. Interleukin-6 and soluble interleukin-6 receptor: Direct stimulation of gp130 and hematopoiesis. Blood 1998, 92, 3495-3504.
109. Wang, Y.; Nesbitt, J.E.; Fuentes, N.L.; Fuller, G.M. Molecular cloning and characterization of the rat liver IL-6 signal transducing molecule, gp130. Genomics 1992, 14, 666-672.
110. Cressman, D.E.; Greenbaum, L.E.; DeAngelis, R.A.; Ciliberto, G.; Furth, E.E.; Poli, V.; Taub, R. Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science 1996, 274, 1379-1383.
111. Liu, Y.; Michalopoulos, G.K.; Zarnegar, R. Structural and functional characterization of the mouse hepatocyte growth factor gene promoter. J. Biol. Chem. 1994, 269, 4152-4160.
112. Sun, R.; Jaruga, B.; Kulkarni, S.; Sun, H.; Gao, B. IL-6 modulates hepatocyte proliferation via induction of HGF/p21cip1: regulation by SOCS3. Biochem. Biophys. Res. Commun. 2005, 338, 1943-1949.
113. Kariv, R.; Enden, A.; Zvibel, I.; Rosner, G.; Brill, S.; Shafritz, D.A.; Halpern, Z.; Oren, R. Triiodothyronine and interleukin-6 (IL-6) induce expression of HGF in an immortalized rat hepatic stellate cell line. Liver Int. 2003, 23, 187-193.
114. Coudriet, G.M.; He, J.; Trucco, M.; Mars, W.M.; Piganelli, J.D. Hepatocyte growth factor modulates interleukin-6 production in bone marrow derived macrophages: Implications for inflammatory mediated diseases. PLoS One 2010, 5, e15384.
115. Gong, R. Multi-target anti-inflammatory action of hepatocyte growth factor. Curr. Opin. Investig. Drugs 2008, 9, 1163-1170.
116. Wrana, J.L.; Attisano, L.; Carcamo, J.; Zentella, A.; Doody, J.; Laiho, M.; Wang, X.F.; Massague, J. TGF beta signals through a heteromeric protein kinase receptor complex. Cell 1992, 71, 1003-1014.
117. Gruppuso, P.A.; Mead, J.E.; Fausto, N. Transforming growth factor receptors in liver regeneration following partial hepatectomy in the rat. Cancer Res. 1990, 50, 1464-1469.
118. Chari, R.S.; Price, D.T.; Sue, S.R.; Meyers, W.C.; Jirtle, R.L. Down-regulation of transforming growth factor beta receptor type I, II, and III during liver regeneration. Am. J. Surg. 1995, 169, 126-131; discussion 131-122.
119. Bissell, D.M.; Wang, S.S.; Jarnagin, W.R.; Roll, F.J. Cell-specific expression of transforming growth factor-beta in rat liver. Evidence for autocrine regulation of hepatocyte proliferation. J. Clin. Invest. 1995, 96, 447-455.
120. Ikeda, H.; Nagoshi, S.; Ohno, A.; Yanase, M.; Maekawa, H.; Fujiwara, K. Activated rat stellate cells express c-met and respond to hepatocyte growth factor to enhance transforming growth factor beta1 expression and DNA synthesis. Biochem. Biophys. Res. Commun. 1998, 250, 769-775.
121. Nakatsukasa, H.; Evarts, R.P.; Hsia, C.C.; Thorgeirsson, S.S. Transforming growth factor-beta 1 and type I procollagen transcripts during regeneration and early fibrosis of rat liver. Lab. Invest. 1990, 63, 171-180.
122. Carr, B.I.; Huang, T.H.; Itakura, K.; Noel, M.; Marceau, N. TGF beta gene transcription in normal and neoplastic liver growth. J. Cell. Biochem. 1989, 39, 477-487.
123. Michalopoulos, G.K.; Bowen, W.C.; Mule, K.; Luo, J. HGF-, EGF-, and dexamethasone-induced gene expression patterns during formation of tissue in hepatic organoid cultures. Gene Expr. 2003, 11, 55-75.
124. McMahon, J.B.; Richards, W.L.; del Campo, A.A.; Song, M.K.; Thorgeirsson, S.S. Differential effects of transforming growth factor-beta on proliferation of normal and malignant rat liver epithelial cells in culture. Cancer Res. 1986, 46, 4665-4671.
125. Houck, K.A.; Cruise, J.L.; Michalopoulos, G. Norepinephrine modulates the growth-inhibitory effect of transforming growth factor-beta in primary rat hepatocyte cultures. J. Cell. Physiol. 1988, 135, 551-555.
126. Russell, W.E.; Coffey, R.J., Jr.; Ouellette, A.J.; Moses, H.L. Type beta transforming growth factor reversibly inhibits the early proliferative response to partial hepatectomy in the rat. Proc. Natl. Acad. Sci. USA 1988, 85, 5126-5130.
127. Jirtle, R.L.; Carr, B.I.; Scott, C.D. Modulation of insulin-like growth factor-II/mannose 6-phosphate receptors and transforming growth factor-beta 1 during liver regeneration. J. Biol. Chem. 1991, 266, 22444-22450.
128. Michalopoulos, G.K.; DeFrances, M.C. Liver regeneration. Science 1997, 276, 60-66.
129. Houck, K.A.; Michalopoulos, G.K. Altered responses of regenerating hepatocytes to norepinephrine and transforming growth factor type beta. J. Cell. Physiol. 1989, 141, 503-509.
130. O'Connor-McCourt, M.D.; Wakefield, L.M. Latent transforming growth factor-beta in serum. A specific complex with alpha 2-macroglobulin. J. Biol. Chem. 1987, 262, 14090-14099.
131. Braun, L.; Mead, J.E.; Panzica, M.; Mikumo, R.; Bell, G.I.; Fausto, N. Transforming growth factor beta mRNA increases during liver regeneration: a possible paracrine mechanism of growth regulation. Proc. Natl. Acad. Sci. USA 1988, 85, 1539-1543.
132. Oe, S.; Lemmer, E.R.; Conner, E.A.; Factor, V.M.; Leveen, P.; Larsson, J.; Karlsson, S.; Thorgeirsson, S.S. Intact signaling by transforming growth factor beta is not required for termination of liver regeneration in mice. Hepatology 2004, 40, 1098-1105.
133. Thenappan, A.; Shukla, V.; Abdul Khalek, F.J.; Li, Y.; Shetty, K.; Liu, P.; Li, L.; Johnson, R.L.; Johnson, L.; Mishra, L. Loss of transforming growth factor beta adaptor protein beta-2 spectrin leads to delayed liver regeneration in mice. Hepatology 2011, 53, 1641-1650.
134. Oben, J.A.; Roskams, T.; Yang, S.; Lin, H.; Sinelli, N.; Torbenson, M.; Smedh, U.; Moran, T.H.; Li, Z.; Huang, J.; Thomas, S.A.; Diehl, A.M. Hepatic fibrogenesis requires sympathetic neurotransmitters. Gut 2004, 53, 438-445.
135. Cruise, J.L.; Knechtle, S.J.; Bollinger, R.R.; Kuhn, C.; Michalopoulos, G. Alpha 1-adrenergic effects and liver regeneration. Hepatology 1987, 7, 1189-1194.
136. Cruise, J.L.; Michalopoulos, G. Norepinephrine and epidermal growth factor: dynamics of their interaction in the stimulation of hepatocyte DNA synthesis. J. Cell. Physiol. 1985, 125, 45-50.
137. Cruise, J.L.; Houck, K.A.; Michalopoulos, G.K. Induction of DNA synthesis in cultured rat hepatocytes through stimulation of alpha 1 adrenoreceptor by norepinephrine. Science 1985, 227, 749-751.
138. Kanamaru, C.; Yasuda, H.; Takeda, M.; Ueda, N.; Suzuki, J.; Tsuchida, T.; Mashima, H.; Ohnishi, H.; Fujita, T. Smad7 is induced by norepinephrine and protects rat hepatocytes from activin A-induced growth inhibition. J. Biol. Chem. 2001, 276, 45636-45641.
139. Han, C.; Bowen, W.C.; Michalopoulos, G.K.; Wu, T. Alpha-1 adrenergic receptor transactivates signal transducer and activator of transcription-3 (Stat3) through activation of Src and epidermal growth factor receptor (EGFR) in hepatocytes. J. Cell. Physiol. 2008, 216, 486-497.
140. Lesurtel, M.; Graf, R.; Aleil, B.; Walther, D.J.; Tian, Y.; Jochum, W.; Gachet, C.; Bader, M.; Clavien, P.A. Platelet-derived serotonin mediates liver regeneration. Science 2006, 312, 104-107.
141. Furrer, K.; Rickenbacher, A.; Tian, Y.; Jochum, W.; Bittermann, A.G.; Kach, A.; Humar, B.; Graf, R.; Moritz, W.; Clavien, P.A. Serotonin reverts age-related capillarization and failure of regeneration in the liver through a VEGF-dependent pathway. Proc. Natl. Acad. Sci. USA 2011, 108, 2945-2950.
142. Matondo, R.B.; Punt, C.; Homberg, J.; Toussaint, M.J.; Kisjes, R.; Korporaal, S.J.; Akkerman, J.W.; Cuppen, E.; de Bruin, A. Deletion of the serotonin transporter in rats disturbs serotonin homeostasis without impairing liver regeneration. Am. J. Physiol. Gastrointest. Liver Physiol. 2009, 296, G963-G968.
143. Huang, W.; Ma, K.; Zhang, J.; Qatanani, M.; Cuvillier, J.; Liu, J.; Dong, B.; Huang, X.; Moore, D.D. Nuclear receptor-dependent bile acid signaling is required for normal liver regeneration. Science. 2006, 312, 233-236.
144. Uppal, H.; Saini, S.P.; Moschetta, A.; Mu, Y.; Zhou, J.; Gong, H.; Zhai, Y.; Ren, S.; Michalopoulos, G.K.; Mangelsdorf, D.J.; Xie, W. Activation of LXRs prevents bile acid toxicity and cholestasis in female mice. Hepatology 2007, 45, 422-432.
145. Keitel, V.; Haussinger, D. TGR5 in the biliary tree. Dig. Dis. 2011, 29, 45-47.
146. Holeek, M. Nutritional modulation of liver regeneration by carbohydrates, lipids, and amino acids: a review. Nutrition 1999, 15, 784-788.
147. Rudnick, D.A.; Davidson, N.O. Functional Relationships between Lipid Metabolism and Liver Regeneration. Int. J. Hepatol. 2012, 549241.
148. Michalopoulos, G.; Pitot, H.C. Primary culture of parenchymal liver cells on collagen membranes. Morphological and biochemical observations. Exp. Cell Res. 1975, 94, 70-78.
149. Lai, H.S.; Chung, Y.C.; Chen, W.J.; Chen, K.M. Rat liver regeneration after partial hepatectomy: effects of insulin, glucagon and epidermal growth factor. J. Formos. Med. Assoc. 1992, 91, 685-690.
150. Starzl, T.E.; Francavilla, A.; Porter, K.A.; Benichou, J.; Jones, A.F. The effect of splanchnic viscera removal upon canine liver regeneration. Surg. Gynecol. Obstet. 1978, 147, 193-207.
151. Weymann, A.; Hartman, E.; Gazit, V.; Wang, C.; Glauber, M.; Turmelle, Y.; Rudnick, D.A. P21 is required for dextrose-mediated inhibition of mouse liver regeneration. Hepatology 2009, 50, 207-215.
152. Caruana, J.A.; Whalen, D.A.; Anthony, W.P.; Sunby, C.R.; Ciechoski, M.P. Paradoxical effects of glucose feeding on liver regeneration and survival after partial hepatectomy. Endocrine Res. 1986, 12, 147-156.
153. McGowan, J.; Atryzek, V.; Fausto, N. Effects of protein-deprivation on the regeneration of rat liver after partial hepatectomy. Biochem. J. 1979, 180, 25-35.
154. Holeček, M.; Šimek, J.; Palička, V.; Zadák, Z. Effect of glucose and branched chain amino acid (BCAA) infusion on onset of liver regeneration and plasma amino acid pattern in partially hepatectomized rats. J. Hepatol. 1991, 13, 14-20.
155. Glende, E.A.; Morgan, W.S. Alteration in liver lipid and lipid fatty acid composition after partial hepatectomy in the rat. Exp. Mol. Path. 1968, 8, 190-200.
156. Gazit, V.; Weymann, A.; Hartman, E.; Finck, B.N.; Hruz, P.W.; Tzekov, A.; Rudnick, D.A. Liver regeneration is impaired in lipodystrophic fatty liver dystrophy mice. Hepatology 2010, 52, 2109-2117.
157. Blaha, V.; Simek, J.; Zadak, Z. Liver regeneration in partially hepatectomized rats infused with carnitine and lipids. Exp. Toxicol. Pathol. 1992, 44, 158, 165-168.
158. Nakatani, T.; Ozawa, K.; Asano, M. Differences in predominant energy substrate in relation to the resected hepatic mass in the phase immediately after hepatectomy. J. Lab. Clin. Med. 1981, 97, 887-898.
159. Zeng, G.; Awan, F.; Otruba, W.; Muller, P.; Apte, U.; Tan, X.; Gandhi, C.; Demetris, A.J.; Monga, S.P. Wnt'er in liver: expression of Wnt and frizzled genes in mouse. Hepatology. 2007, 45, 195-204.
160. Apte, U.; Zeng, G.; Muller, P.; Tan, X.; Micsenyi, A.; Cieply, B.; Dai, C.; Liu, Y.; Kaestner, K.H.; Monga, S.P. Activation of Wnt/beta-catenin pathway during hepatocyte growth factorinduced hepatomegaly in mice. Hepatology 2006, 44, 992-1002.
161. Monga, S.P.; Mars, W.M.; Pediaditakis, P.; Bell, A.; Mule, K.; Bowen, W.C.; Wang, X.; Zarnegar, R.; Michalopoulos, G.K. Hepatocyte growth factor induces Wnt-independent nuclear translocation of beta-catenin after Met-beta-catenin dissociation in hepatocytes. Cancer Res. 2002, 62, 2064-2071.
162. Sodhi, D.; Micsenyi, A.; Bowen, W.C.; Monga, D.K.; Talavera, J.C.; Monga, S.P. Morpholino oligonucleotide-triggered beta-catenin knockdown compromises normal liver regeneration. J. Hepatol. 2005, 43, 132-141.
163. Tan, X.; Behari, J.; Cieply, B.; Michalopoulos, G.K.; Monga, S.P. Conditional deletion of betacatenin reveals its role in liver growth and regeneration. Gastroenterology 2006, 131, 1561-1572.
164. Rangwala, F.; Guy, C.D.; Lu, J.; Suzuki, A.; Burchette, J.L.; Abdelmalek, M.F.; Chen, W.; Diehl, A.M. Increased production of sonic hedgehog by ballooned hepatocytes. J. Pathol. 2011, 224, 401-410.
165. Witek, R.P.; Yang, L.; Liu, R.; Jung, Y.; Omenetti, A.; Syn, W.K.; Choi, S.S.; Cheong, Y.; Fearing, C.M.; Agboola, K.M.; Chen, W.; Diehl, A.M. Liver cell-derived microparticles activate hedgehog signaling and alter gene expression in hepatic endothelial cells. Gastroenterology 2009, 136, 320-330 e322.
166. Ochoa, B.; Syn, W.K.; Delgado, I.; Karaca, G.F.; Jung, Y.; Wang, J.; Zubiaga, A.M.; Fresnedo, O.; Omenetti, A.; Zdanowicz, M.; Choi, S.S.; Diehl, A.M. Hedgehog signaling is critical for normal liver regeneration after partial hepatectomy in mice. Hepatology 2010, 51, 1712-1723.
167. Capurro, M.I.; Xu, P.; Shi, W.; Li, F.; Jia, A.; Filmus, J. Glypican-3 inhibits Hedgehog signaling during development by competing with patched for Hedgehog binding. Dev. Cell. 2008, 14, 700-711.
168. Kan, M.; Wu, X.; Wang, F.; McKeehan, W.L. Specificity for fibroblast growth factors determined by heparan sulfate in a binary complex with the receptor kinase. J. Biol. Chem. 1999, 274, 15947-15952.
169. Houck, K.A.; Zarnegar, R.; Muga, S.J.; Michalopoulos, G.K. Acidic fibroblast growth factor (HBGF-1) stimulates DNA synthesis in primary rat hepatocyte cultures. J. Cell. Physiol. 1990, 143, 129-132.
170. Strain, A.J.; McGuinness, G.; Rubin, J.S.; Aaronson, S.A. Keratinocyte growth factor and fibroblast growth factor action on DNA synthesis in rat and human hepatocytes: Modulation by heparin. Exp. Cell Res. 1994, 210, 253-259.
171. Steiling, H.; Wustefeld, T.; Bugnon, P.; Brauchle, M.; Fassler, R.; Teupser, D.; Thiery, J.; Gordon, J.I.; Trautwein, C.; Werner, S. Fibroblast growth factor receptor signalling is crucial for liver homeostasis and regeneration. Oncogene 2003, 22, 4380-4388.
172. Grisham, J.W. A morphologic study of deoxyribonucleic acid synthesis and cell proliferation in regenerating rat liver; autoradiography with thymidine-H3. Cancer Res. 1962, 22, 842-849.
173. Widmann, J.J.; Fahimi, H.D. Proliferation of mononuclear phagocytes (Kupffer cells) and endothelial cells in regenerating rat liver. A light and electron microscopic cytochemical study. Am. J. Pathol. 1975, 80, 349-366.
174. Tanaka, Y.; Mak, K.M.; Lieber, C.S. Immunohistochemical detection of proliferating lipocytes in regenerating rat liver. J. Pathol. 1990, 160, 129-134.
175. Stocker, E.; Heine, W.D. Regeneration of liver parenchyma under normal and pathological conditions. Beitr. Pathol. 1971, 144, 400-408.
176. Stocker, E.; Heine, W.D. Proliferation and regeneration in liver and kidney of juvenile rats. Autoradiographic studies after continuous infusion of 3H-thymidine (author's transl). Verh. Dtsch. Ges. Pathol. 1971, 55, 483-488.
177. Stocker, E.; Schultze, B.; Heine, W.D.; Liebscher, H. Growth and regeneration in parenchymatous organs of the rat. Autoradiographic investigations with 3 H-thymidin. Z. Zellforsch. Mikrosk. Anat. 1972, 125, 306-331.
178. Schmucker, D.L.; Sanchez, H. Liver regeneration and aging: a current perspective. Curr. Gerontol. Geriatr. Res. 2011, 2011, 526379.
179. Stocker, E.; Wullstein, H.K.; Brau, G. Capacity of regeneration in liver epithelia of juvenile, repeated partially hepatectomized rats. Autoradiographic studies after continous infusion of 3Hthymidine (author's transl). Virchows Arch. B Cell. Pathol. 1973, 14, 93-103.
180. Overturf, K.; al-Dhalimy, M.; Ou, C.N.; Finegold, M.; Grompe, M. Serial transplantation reveals the stem-cell-like regenerative potential of adult mouse hepatocytes. Am. J. Pathol. 1997, 151, 1273-1280.
181. Bhave, V.S.; Paranjpe, S.; Bowen, W.C.; Donthamsetty, S.; Bell, A.W.; Khillan, J.S.; Michalopoulos, G.K. Genes inducing iPS phenotype play a role in hepatocyte survival and proliferation in vitro and liver regeneration in vivo. Hepatology 2011, 54, 1360-1370.
182. Kan, M.; Huang, J.S.; Mansson, P.E.; Yasumitsu, H.; Carr, B.; McKeehan, W.L. Heparinbinding growth factor type 1 (acidic fibroblast growth factor): a potential biphasic autocrine and paracrine regulator of hepatocyte regeneration. Proc. Natl. Acad. Sci. USA 1989, 86, 7432-7436.
183. Borkham-Kamphorst, E.; Kovalenko, E.; van Roeyen, C.R.; Gassler, N.; Bomble, M.; Ostendorf, T.; Floege, J.; Gressner, A.M.; Weiskirchen, R. Platelet-derived growth factor isoform expression in carbon tetrachloride-induced chronic liver injury. Lab. Invest. 2008, 88, 1090-1100.
184. Ross, M.A.; Sander, C.M.; Kleeb, T.B.; Watkins, S.C.; Stolz, D.B. Spatiotemporal expression of angiogenesis growth factor receptors during the revascularization of regenerating rat liver. Hepatology 2001, 34, 1135-1148.
185. Martinez-Hernandez, A.; Amenta, P.S. The extracellular matrix in hepatic regeneration. FASEB J. 1995, 9, 1401-1410.
186. Wack, K.E.; Ross, M.A.; Zegarra, V.; Sysko, L.R.; Watkins, S.C.; Stolz, D.B. Sinusoidal ultrastructure evaluated during the revascularization of regenerating rat liver. Hepatology 2001, 33, 363-378.
187. Fujii, H.; Hirose, T.; Oe, S.; Yasuchika, K.; Azuma, H.; Fujikawa, T.; Nagao, M.; Yamaoka, Y. Contribution of bone marrow cells to liver regeneration after partial hepatectomy in mice. J. Hepatol. 2002, 36, 653-659.
188. Zocco, M.A.; Piscaglia, A.C.; Giuliante, F.; Arena, V.; Novi, M.; Rinninella, E.; Tortora, A.; Rumi, C.; Nuzzo, G.; Vecchio, F.M.; Bombardieri, G.; Gasbarrini, A. CD133+ stem cell mobilization after partial hepatectomy depends on resection extent and underlying disease. Dig. Liver Dis. 2011, 43, 147-154.
189. Wang, L.; Wang, X.; Xie, G.; Hill, C.K.; DeLeve, L.D. Liver sinusoidal endothelial cell progenitor cells promote liver regeneration in rats. J. Clin. Invest. 2012, 122, 1567-1573.
190. Wang, L.; Wang, X.; Chiu, J.D.; van de Ven, G.; Gaarde, W.A.; Deleve, L.D. Hepatic Vascular Endothelial Growth Factor Regulates Recruitment of Rat Liver Sinusoidal Endothelial Cell Progenitor Cells. Gastroenterology 2012, 143, 1555-1563.
191. Lagasse, E.; Connors, H.; Al-Dhalimy, M.; Reitsma, M.; Dohse, M.; Osborne, L.; Wang, X.; Finegold, M.; Weissman, I.L.; Grompe, M. Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nat. Med. 2000, 6, 1229-1234.
192. Petersen, B.E.; Bowen, W.C.; Patrene, K.D.; Mars, W.M.; Sullivan, A.K.; Murase, N.; Boggs, S.S.; Greenberger, J.S.; Goff, J.P. Bone marrow as a potential source of hepatic oval cells. Science 1999, 284, 1168-1170.
193. Terada, N.; Hamazaki, T.; Oka, M.; Hoki, M.; Mastalerz, D.M.; Nakano, Y.; Meyer, E.M.; Morel, L.; Petersen, B.E.; Scott, E.W. Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion. Nature 2002, 416, 542-545.
194. Wang, X.; Willenbring, H.; Akkari, Y.; Torimaru, Y.; Foster, M.; Al-Dhalimy, M.; Lagasse, E.; Finegold, M.; Olson, S.; Grompe, M. Cell fusion is the principal source of bone-marrow-derived hepatocytes. Nature. 2003, 422, 897-901.
195. Kuwahara, R.; Kofman, A.V.; Landis, C.S.; Swenson, E.S.; Barendswaard, E.; Theise, N.D. The hepatic stem cell niche: identification by label-retaining cell assay. Hepatology 2008, 47, 1994-2002.
196. Dolle, L.; Best, J.; Mei, J.; Al Battah, F.; Reynaert, H.; van Grunsven, L.A.; Geerts, A. The quest for liver progenitor cells: a practical point of view. J. Hepatol. 2010, 52, 117-129.
197. Evarts, R.P.; Nagy, P.; Nakatsukasa, H.; Marsden, E.; Thorgeirsson, S.S. In vivo differentiation of rat liver oval cells into hepatocytes. Cancer Res. 1989, 49, 1541-1547.
198. Trautwein, C.; Will, M.; Kubicka, S.; Rakemann, T.; Flemming, P.; Manns, M.P. 2-acetaminofluorene blocks cell cycle progression after hepatectomy by p21 induction and lack of cyclin E expression. Oncogene 1999, 18, 6443-6453.
199. Limaye, P.B.; Alarcon, G.; Walls, A.L.; Nalesnik, M.A.; Michalopoulos, G.K.; Demetris, A.J.; Ochoa, E.R. Expression of specific hepatocyte and cholangiocyte transcription factors in human liver disease and embryonic development. Lab. Invest. 2008, 88, 865-872.
200. Petersen, B.E.; Goff, J.P.; Greenberger, J.S.; Michalopoulos, G.K. Hepatic oval cells express the hematopoietic stem cell marker Thy-1 in the rat. Hepatology 1998, 27, 433-445.
201. Evarts, R.P.; Hu, Z.; Fujio, K.; Marsden, E.R.; Thorgeirsson, S.S. Activation of hepatic stem cell compartment in the rat: role of transforming growth factor alpha, hepatocyte growth factor, and acidic fibroblast growth factor in early proliferation. Cell Growth Differ. 1993, 4, 555-561.
202. Darwiche, H.; Oh, S.H.; Steiger-Luther, N.C.; Williams, J.M.; Pintilie, D.G.; Shupe, T.D.; Petersen, B.E. Inhibition of Notch signaling affects hepatic oval cell response in rat model of 2AAF-PH. Hepat. Med. 2011, 3, 89-98.
203. Thenappan, A.; Li, Y.; Kitisin, K.; Rashid, A.; Shetty, K.; Johnson, L.; Mishra, L. Role of transforming growth factor beta signaling and expansion of progenitor cells in regenerating liver. Hepatology 2010, 51, 1373-1382.
204. Erker, L.; Grompe, M. Signaling networks in hepatic oval cell activation. Stem Cell Res. 2007, 1, 90-102.
205. Jakubowski, A.; Ambrose, C.; Parr, M.; Lincecum, J.M.; Wang, M.Z.; Zheng, T.S.; Browning, B.; Michaelson, J.S.; Baetscher, M.; Wang, B.; Bissell, D.M.; Burkly, L.C. TWEAK induces liver progenitor cell proliferation. J. Clin. Invest. 2005, 115, 2330-2340.
206. Mavier, P.; Martin, N.; Couchie, D.; Preaux, A.M.; Laperche, Y.; Zafrani, E.S. Expression of stromal cell-derived factor-1 and of its receptor CXCR4 in liver regeneration from oval cells in rat. Am. J. Pathol. 2004, 165, 1969-1977.
207. Theise, N.D.; Saxena, R.; Portmann, B.C.; Thung, S.N.; Yee, H.; Chiriboga, L.; Kumar, A.; Crawford, J.M. The canals of Hering and hepatic stem cells in humans. Hepatology 1999, 30, 1425-1433.
208. Nagy, P.; Bisgaard, H.C.; Thorgeirsson, S.S. Expression of hepatic transcription factors during liver development and oval cell differentiation. J. Cell. Biol. 1994, 126, 223-233.
209. Petersen, B.E.; Zajac, V.F.; Michalopoulos, G.K. Bile ductular damage induced by methylene dianiline inhibits oval cell activation. Am. J. Pathol. 1997, 151, 905-909.
210. Demetris, A.J.; Seaberg, E.C.; Wennerberg, A.; Ionellie, J.; Michalopoulos, G. Ductular reaction after submassive necrosis in humans. Special emphasis on analysis of ductular hepatocytes. Am. J. Pathol. 1996, 149, 439-448.
211. Michalopoulos, G.K.; Barua, L.; Bowen, W.C. Transdifferentiation of rat hepatocytes into biliary cells after bile duct ligation and toxic biliary injury. Hepatology 2005, 41, 535-544.
212. Kordes, C.; Sawitza, I.; Muller-Marbach, A.; Ale-Agha, N.; Keitel, V.; Klonowski-Stumpe, H.; Haussinger, D. CD133+ hepatic stellate cells are progenitor cells. Biochem. Biophys. Res. Commun. 2007, 352, 410-417.
213. Yang, L.; Jung, Y.; Omenetti, A.; Witek, R.P.; Choi, S.; Vandongen, H.M.; Huang, J.; Alpini, G.D.; Diehl, A.M. Fate-mapping evidence that hepatic stellate cells are epithelial progenitors in adult mouse livers. Stem Cells. 2008, 26, 2104-2113.
214. Xu, C.; Yang, Y.; Yang, J.; Chen, X.; Wang, G. Analysis of the role of the integrin signaling pathway in hepatocytes during rat liver regeneration. Cell Mol Biol Lett. 2012, 17, 274-288.
215. Legate, K.R.; Montanez, E.; Kudlacek, O.; Fassler, R. ILK, PINCH and parvin: the tIPP of integrin signalling. Nat. Rev. Mol. Cell. Biol. 2006, 7, 20-31.
216. Gkretsi, V.; Bowen, W.C.; Yang, Y.; Wu, C.; Michalopoulos, G.K. Integrin-linked kinase is involved in matrix-induced hepatocyte differentiation. Biochem. Biophys. Res. Commun. 2007, 353, 638-643.
217. Gkretsi, V.; Apte, U.; Mars, W.M.; Bowen, W.C.; Luo, J.H.; Yang, Y.; Yu, Y.P.; Orr, A.; St-Arnaud, R.; Dedhar, S.; Kaestner, K.H.; Wu, C.; Michalopoulos, G.K. Liver-specific ablation of integrin-linked kinase in mice results in abnormal histology, enhanced cell proliferation, and hepatomegaly. Hepatology 2008, 48, 1932-1941.
218. Hippo, Y.; Watanabe, K.; Watanabe, A.; Midorikawa, Y.; Yamamoto, S.; Ihara, S.; Tokita, S.; Iwanari, H.; Ito, Y.; Nakano, K.; Nezu, J.; Tsunoda, H.; Yoshino, T.; Ohizumi, I.; Tsuchiya, M.; Ohnishi, S.; Makuuchi, M.; Hamakubo, T.; Kodama, T.; Aburatani, H. Identification of soluble NH2-terminal fragment of glypican-3 as a serological marker for early-stage hepatocellular carcinoma. Cancer Res. 2004, 64, 2418-2423.
219. Pilia, G.; Hughes-Benzie, R.M.; MacKenzie, A.; Baybayan, P.; Chen, E.Y.; Huber, R.; Neri, G.; Cao, A.; Forabosco, A.; Schlessinger, D. Mutations in GPC3, a glypican gene, cause the Simpson-Golabi-Behmel overgrowth syndrome. Nat. Genet. 1996, 12, 241-247.
220. Liu, B.; Paranjpe, S.; Bowen, W.C.; Bell, A.W.; Luo, J.H.; Yu, Y.P.; Mars, W.M.; Michalopoulos, G.K. Investigation of the role of glypican 3 in liver regeneration and hepatocyte proliferation. Am. J. Pathol. 2009, 175, 717-724.
221. Ichikawa, T.; Zhang, Y.Q.; Kogure, K.; Hasegawa, Y.; Takagi, H.; Mori, M.; Kojima, I. Transforming growth factor beta and activin tonically inhibit DNA synthesis in the rat liver. Hepatology 2001, 34, 918-925.
222. Buraschi, S.; Pal, N.; Tyler-Rubinstein, N.; Owens, R.T.; Neill, T.; Iozzo, R.V. Decorin antagonizes Met receptor activity and down-regulates {beta}-catenin and Myc levels. J. Biol. Chem. 2010, 285, 42075-42085.
223. Zhu, J.X.; Goldoni, S.; Bix, G.; Owens, R.T.; McQuillan, D.J.; Reed, C.C.; Iozzo, R.V. Decorin evokes protracted internalization and degradation of the epidermal growth factor receptor via caveolar endocytosis. J. Biol. Chem. 2005, 280, 32468-32479.
224. Avruch, J.; Zhou, D.; Fitamant, J.; Bardeesy, N. Mst1/2 signalling to Yap: gatekeeper for liver size and tumour development. Br. J. Cancer. 2011, 104, 24-32.
225. Dong, J.; Feldmann, G.; Huang, J.; Wu, S.; Zhang, N.; Comerford, S.A.; Gayyed, M.F.; Anders, R.A.; Maitra, A.; Pan, D. Elucidation of a universal size-control mechanism in Drosophila and mammals. Cell 2007, 130, 1120-1133.
226. Lu, L.; Li, Y.; Kim, S.M.; Bossuyt, W.; Liu, P.; Qiu, Q.; Wang, Y.; Halder, G.; Finegold, M.J.; Lee, J.S.; Johnson, R.L. Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liver. Proc. Natl. Acad. Sci. USA 2010, 107, 1437-1442.
227. Song, H.; Mak, K.K.; Topol, L.; Yun, K.; Hu, J.; Garrett, L.; Chen, Y.; Park, O.; Chang, J.; Simpson, R.M.; Wang, C.Y.; Gao, B.; Jiang, J.; Yang, Y. Mammalian Mst1 and Mst2 kinases play essential roles in organ size control and tumor suppression. Proc. Natl. Acad. Sci. USA 2010, 107, 1431-1436.
228. Pahlavan, P.S.; Feldmann, R.E., Jr.; Zavos, C.; Kountouras, J. Prometheus' challenge: molecular, cellular and systemic aspects of liver regeneration. J. Surg. Res. 2006, 134, 238-251.
229. Humar, A.; Kosari, K.; Sielaff, T.D.; Glessing, B.; Gomes, M.; Dietz, C.; Rosen, G.; Lake, J.; Payne, W.D. Liver regeneration after adult living donor and deceased donor split-liver transplants. Liver Transpl. 2004, 10, 374-378.